SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Singer who wrote (5672)2/26/1998 5:24:00 PM
From: Bill Fischofer  Read Replies (1) of 23519
 
"Competition"

From the Yahoo profile on MCHM: "For the nine months ended 9/30/97, revenues fell 41% to $51 thousand. Net loss rose 13% to $2.8 million. Revenues reflect lower income from completed research contracts. Higher loss reflects the management and execution of ongoing clinical trials."

Hardly competition worth mentioning.

I've traded VVUS profitably twice since the December selloff and am looking for a reentry point for a longer-term hold. VVUS is clearly the best play on this seldom-mentioned aspect of the "graying of America".
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News